IGNYTE: An open-label, multicenter, phase 1/2 (Ph 1/2) clinical trial of RP1 +- nivolumab in patients with advanced solid tumors
RP-1;Nivolumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: IGNYTE: An open-label, multicenter, phase 1/2 (Ph 1/2) clinical trial of RP1 +- nivolumab in patients with advanced solid tumors ### Output: RP-1;Nivolumab